ArticleOpen forum infectious diseases2021

Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study.

Tristan Ferry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.